The United States Senate confirmed Dr. Erica Schwartz as director of the Centers for Disease Control and Prevention on Wednesday, August 5, 2026, by a vote of 51-44. The 54-year-old physician and lawyer is the agency’s 22nd leader and its first confirmed director in nearly a year.
Schwartz takes charge of the Atlanta-based agency after layoffs and resignations reduced its workforce by more than 3,000 employees, according to The Associated Press. Her appointment follows months of questions about whether the CDC can make science-based decisions amid pressure from President Donald Trump’s administration and Health Secretary Robert F. Kennedy Jr.
At a glance:
- Senate vote: 51-44 on August 5, 2026.
- Schwartz is the CDC’s 22nd leader and first confirmed director in nearly a year.
- The agency has lost more than 3,000 employees through layoffs and resignations.
- She previously served as deputy surgeon general and has medical and law degrees.
Why Schwartz’s confirmation was uncertain
Schwartz’s nomination faced scrutiny during a July 15 hearing before the Senate Health, Education, Labor and Pensions Committee. Republican Chairman Bill Cassidy questioned whether she would resist directives from Kennedy if they conflicted with scientific evidence or established public health practice.
Related coverage: FDA Panel to Decide on Approval of Controversial Peptides Endorsed by Robert F Kennedy Jr.
Cassidy later said he had spoken with Schwartz and others familiar with her work, and that those conversations increased his confidence in the nominee. Her confirmation makes Schwartz President Trump’s third nominee for CDC director in roughly 18 months.
The challenges awaiting the new CDC director
The CDC has experienced low morale and a succession of temporary leaders since Trump returned to office. The agency’s staffing losses have come as public health officials confront falling childhood vaccination rates, the worst U.S. measles resurgence in three decades and a cyclospora outbreak, according to the supplied report.
Public health groups have urged Schwartz to protect career employees, defend evidence-based guidance and maintain the agency’s independence. The American Public Health Association said the CDC needs stability, experienced leadership and a commitment to science.
More context: Health teams in Yemen intensify efforts to control deadly dengue fever spread.
Schwartz’s background and immediate test
Schwartz has medical and law degrees, previously served as deputy surgeon general and held a leadership role with the U.S. Coast Guard. Public health experts have expressed cautious optimism that her qualifications can help stabilize the agency.
Her first major test will be whether she can rebuild trust among CDC employees and the public while navigating the administration’s vaccine policies. The National Public Health Coalition, representing former and current CDC workers, said she must show that her leadership serves science rather than political demands.
Related coverage:
No comments yet. Start the discussion.